Home
Cubist Pharmaceuticals Inc.

Cubist Pharmaceuticals Inc. Market Share Analysis for January 2026

Industry: N/A

Domaincubist.com

Year Founded1992

Employees501 - 1000

Annual Revenue> $1B

Cubist Pharmaceuticals Inc.

Cubist Pharmaceuticals Inc. (including company regionals)

cubist.com

See more website traffic and engagement information

Cubist Pharmaceuticals Inc. Revenue up to January 2026 is > 1B

revenue generated by Cubist Pharmaceuticals Inc. top domains

Cubist Pharmaceuticals Inc. top domains revenue over 3 years

Revenue for Cubist Pharmaceuticals Inc. top domains

cubist.com> 1B

See more with Sales Intelligence

Total visits to Cubist Pharmaceuticals Inc.'s top domains

Understand Cubist Pharmaceuticals Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Cubist Pharmaceuticals Inc.'s top domains

Analyze Cubist Pharmaceuticals Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Cubist Pharmaceuticals Inc.'s top domains

See how Cubist Pharmaceuticals Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Cubist Pharmaceuticals Inc. top competitors by domain

Top similar sites in January 2026, ranked by their affinity

optimerpharma.comCompany NameOptimer PharmaceuticalsEmployees201 - 500HQUnited States, New Jersey, Jersey CityAnnual revenue$75M - $100MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Cubist Pharmaceuticals Inc.

These are the website technologies, by industry, used by Cubist Pharmaceuticals Inc. top domains

Audio Video Media (3)

Vimeo

Advertising (1)

DoubleClick

Content Management System (1)

Kentico

Conversion & Analytics (1)

Google Analytics

More Technologies

3

See all

News & Signals from Cubist Pharmaceuticals Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCubist acquires Triusrx for $700M.He was also co-founder and chief financial officer of Trius Therapeutics, which was acquired by Cubist Pharmaceuticals for over $700 million.

NewsMerck acquired Cubist for $9.5B on Jan 1st '15.The dispute involves a Merck shareholder and his opposition to Merck's $8.4 billion acquisition of Cubist Pharmaceuticals.